Sarcoidosis--1977.
Sarcoidosis is defined as a multisystem disorder characterised by the finding of epithelioid cell granulomas in more than one system. Diagnosis is aided by the use of the Kveim Siltzbach skin test and the development of an "in vitro" Kmif test is discussed. Despite extensive researches the causative agent(s) remains unknown. The granulomas, morphologically, on light and electron microscopy and histochemistry may be indistinguishable from those caused by known agents. Inclusion bodies are also non specific. Central necrosis is rare, and can be usually distinguished from caseation. The close relationship between the monocyte derived, epithelioid cells and lymphocytes is emphasised. Evidence is accumulating that epithelioid cells in sarcoid type granulomas are primarily synthesising rather than phagocytic cells. The products are considered to be mucoglycoproteins and may have both local and systemic actions. Locally it is suggested that the products may be lymphokines which react with associated thymic derived (T) lymphocytes and mononuclear cells and thus play a role in perpetuating the granulomas. Epithelioid cells may also be a source of circulating T lymphocyte function depressants. It has further been suggested that epitheloid cells are the source of the raised angiotensin converting enzyme found in sarcoid sera. Study of epithelioid cell granulomas in sarcoidosis, despite the disappointing lack of evidence of a causative sarcoid agent(s), is thus of considerable interest in furthering knowledge of many diseases characterised by these curious cellular foci.
D006099:Granuloma / Q000473:pathology; D006801:Humans; D002479:Inclusion Bodies; D007731:Kveim Test; D008214:Lymphocytes; D008222:Lymphokines; D008854:Microscopy, Electron; D009336:Necrosis; D007703:Peptidyl-Dipeptidase A / Q000032:analysis; D010587:Phagocytosis; D012507:Sarcoidosis / Q000175:diagnosis / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D013601:T-Lymphocytes
D008222:Lymphokines; D007703:Peptidyl-Dipeptidase A